XiFin Appoints Erik Sallee as Chief Financial Officer
February 21, 2024CFO Brings Extensive Capital Markets Experience Leading Companies Through Market Expansion
(SAN DIEGO, CA) XiFin, Inc., a leading provider of innovative healthcare information technologies and services that deliver artificial intelligence (AI)-enabled operational efficiency, interoperability, and simplicity, announced today that it has appointed Erik Sallee as its new chief financial officer and executive vice president.
Prior to joining XiFin, Sallee was CFO at Intuitive Machines (NASDAQ: LUNR), a diversified space exploration company recognized for leading the United States’ return to the moon for the first time since Apollo. In this role, he guided the company from Series B to a successful public listing on the NASDAQ, raising substantial capital in the process.
Recognized for skillfully navigating finance within best-in-class organizations throughout his career, Sallee joins at a pivotal moment in XiFin’s trajectory, as the company positions itself for growth, pursuing timely market opportunities through resourceful financial strategies.
“Erik’s exceptional standing as a financial leader and his track record of shaping financial strategies for innovative and swiftly growing enterprises are vital to XiFin,” said XiFin Executive Chair and Chief Executive Officer Lâle White. “Erik is perfectly suited to accelerate our plans for growth as we focus on market expansion in radiology, pharmacy, and hospital services.”
“I’m proud to be joining XiFin’s mission-driven team to shape the future of healthcare,” said Sallee. “XiFin’s success is rooted in delivering cutting-edge technology and exceptional value that empower our customers to provide the best possible healthcare. I look forward to working with XiFin’s visionary leaders to advance this thriving business model and capitalize on our growth opportunities.”
In addition to driving the implementation of XiFin’s pivotal financial and market expansion strategies, Sallee will lead XiFin’s administrative finance operations, emphasizing a commitment to the principles of “servant leadership” with a focus on accountability, adaptability, efficiency, and greater profitability.
Sallee began his career in the U.S. Marine Corps, and has since held various senior and executive finance roles. In 2013, he was appointed CFO of Raytheon Solipsys, followed by L3 Technologies, Blue Origin, and Intuitive Machines. He earned a B.S. in Political Science from Vanderbilt University and an M.S. and M.B.A. in Finance from University of Maryland College Park. He attended The Wharton School of Business Executive Leadership Program in 2017 and is a licensed Certified Public Accountant.
About XiFin
XiFin is a healthcare information technology company that empowers healthcare organizations to navigate an increasingly complex and evolving healthcare landscape. Through innovative AI-enabled technologies and services, we deliver operational efficiency, interoperability, and simplicity. The company’s revenue cycle management, clinical workflow enablement, laboratory information system, and patient engagement solutions enable organizations to achieve stronger finances, streamline operations, and develop industry-leading business strategies. XiFin solutions deliver THE POWER TO DO GOOD™ so that healthcare organizations can do more good for more patients. Visit www.XiFin.com, follow XiFin on LinkedIn, or subscribe to the XiFin blog to learn more.
Recent Press Releases
-
Feb 21, 2024
XiFin Launches Payor Intelligence Hub, Expands Payor Rate Transparency Monitor with Major Payor Additions
-
Feb 21, 2024
XiFin CEO Lâle White to Discuss Systemic Change Needed in the Shifting Diagnostics Market at the CCLA Annual Conference
-
Feb 21, 2024
XiFin Pharmacy Solutions Invites Pharmacy Professionals to Share Insights on the Critical Success Factors to Forge the Future of Pharmacy Care
-
Feb 21, 2024
XiFin and Drug Store News to Host “Forging the Future of Pharmacy” Webinar to Advocate for Expanded Pharmacy Care
-
Feb 21, 2024
XiFin Earns 2024 HITRUST R2 Certification for Second Two-Year Term